tiprankstipranks
Verastem (DE:2VSA)
FRANKFURT:2VSA
Germany Market
2VSA
Verastem
RESEARCH TOOLSreports

Verastem (2VSA) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

2VSA Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Verastem
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2VSA Stock 12 Month Forecast

Average Price Target

€12.46
▲(136.49% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Verastem in the last 3 months. The average price target is €12.46 with a high forecast of €15.55 and a low forecast of €6.91. The average price target represents a 136.49% change from the last price of €5.27.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"€2","9":"€9","16":"€16","5.5":"€5.5","12.5":"€12.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15.54786792,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€15.55</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.462973491428572,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€12.46</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.91016352,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€6.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,5.5,9,12.5,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.923,5.740297532307692,6.557595064615384,7.374892596923077,8.19219012923077,9.009487661538461,9.826785193846154,10.644082726153847,11.461380258461539,12.27867779076923,13.095975323076923,13.913272855384616,14.730570387692309,{"y":15.54786792,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.923,5.502997960879121,6.082995921758242,6.6629938826373625,7.242991843516483,7.822989804395604,8.402987765274727,8.982985726153846,9.562983687032968,10.142981647912087,10.72297960879121,11.302977569670329,11.882975530549452,{"y":12.462973491428572,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.923,5.075858732307692,5.228717464615385,5.381576196923077,5.53443492923077,5.687293661538462,5.840152393846154,5.993011126153846,6.1458698584615385,6.298728590769231,6.451587323076923,6.604446055384615,6.757304787692307,{"y":6.91016352,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.2,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.8,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.6,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.15,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.96,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.54,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.46,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.552,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.67,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.305,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.923,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€15.55Average Price Target€12.46Lowest Price Target€6.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on DE:2VSA
Graig Suvannavejh
Mizuho Securities
Mizuho Securities
€12.09→€11.23
Buy
113.07%
Upside
Reiterated
08/10/26
Verastem price target lowered to $13 from $14 at MizuhoVerastem price target lowered to $13 from $14 at Mizuho
H.C. Wainwright Analyst forecast on DE:2VSA
Andres Y. Maldonado
H.C. Wainwright
H.C. Wainwright
€15.55
Buy
195.03%
Upside
Reiterated
08/07/26
Verastem Reiterated as Buy on Strong AVMAPKI FAKZYNJA Momentum, VS-7375 Progress; $18 Price Target Maintained
Guggenheim Analyst forecast on DE:2VSA
Michael Schmidt
Guggenheim
Guggenheim
€12.09→€10.37
Buy
96.68%
Upside
Reiterated
08/06/26
Verastem price target lowered to $12 from $14 at GuggenheimVerastem price target lowered to $12 from $14 at Guggenheim
RBC Capital Analyst forecast on DE:2VSA
Leonid Timashev
RBC Capital
RBC Capital
€12.09
Buy
129.46%
Upside
Reiterated
08/06/26
RBC Capital Keeps Their Buy Rating on Verastem (VSTM)
BTIG Analyst forecast on DE:2VSA
Jeet Mukherjee
BTIG
BTIG
€15.55
Buy
195.03%
Upside
Reiterated
08/06/26
Verastem (VSTM) Receives a Buy from BTIG
Alliance Global Partners Analyst forecast on DE:2VSA
James Molloy
Alliance Global Partners
Alliance Global Partners
€15.55
Buy
195.03%
Upside
Reiterated
06/24/26
Verastem (VSTM) Gets a Buy from Alliance Global Partners
Jefferies Analyst forecast on DE:2VSA
Faisal Khurshid
Jefferies
Jefferies
€12.96→€6.91
Buy
31.12%
Upside
Reiterated
06/23/26
Verastem price target lowered to $8 from $15 at JefferiesVerastem price target lowered to $8 from $15 at Jefferies
B. Riley Securities Analyst forecast on DE:2VSA
Unknown Analyst
B. Riley Securities
Not Ranked
B. Riley Securities
€13.82
Buy
162.25%
Upside
Initiated
05/22/26
Verastem (VSTM) Receives a Buy from B. Riley Securities
Cantor Fitzgerald Analyst forecast on DE:2VSA
Eric Schmidt FCA
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Initiated
10/16/25
Verastem assumed with an Overweight at Cantor FitzgeraldVerastem assumed with an Overweight at Cantor Fitzgerald
Wolfe Research Analyst forecast on DE:2VSA
Kalpit Patel
Wolfe Research
Wolfe Research
€13.82
Buy
162.25%
Upside
Reiterated
10/10/25
B. Riley Securities Reaffirms Their Buy Rating on Verastem (VSTM)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on DE:2VSA
Graig Suvannavejh
Mizuho Securities
Mizuho Securities
€12.09→€11.23
Buy
113.07%
Upside
Reiterated
08/10/26
Verastem price target lowered to $13 from $14 at MizuhoVerastem price target lowered to $13 from $14 at Mizuho
H.C. Wainwright Analyst forecast on DE:2VSA
Andres Y. Maldonado
H.C. Wainwright
H.C. Wainwright
€15.55
Buy
195.03%
Upside
Reiterated
08/07/26
Verastem Reiterated as Buy on Strong AVMAPKI FAKZYNJA Momentum, VS-7375 Progress; $18 Price Target Maintained
Guggenheim Analyst forecast on DE:2VSA
Michael Schmidt
Guggenheim
Guggenheim
€12.09→€10.37
Buy
96.68%
Upside
Reiterated
08/06/26
Verastem price target lowered to $12 from $14 at GuggenheimVerastem price target lowered to $12 from $14 at Guggenheim
RBC Capital Analyst forecast on DE:2VSA
Leonid Timashev
RBC Capital
RBC Capital
€12.09
Buy
129.46%
Upside
Reiterated
08/06/26
RBC Capital Keeps Their Buy Rating on Verastem (VSTM)
BTIG Analyst forecast on DE:2VSA
Jeet Mukherjee
BTIG
BTIG
€15.55
Buy
195.03%
Upside
Reiterated
08/06/26
Verastem (VSTM) Receives a Buy from BTIG
Alliance Global Partners Analyst forecast on DE:2VSA
James Molloy
Alliance Global Partners
Alliance Global Partners
€15.55
Buy
195.03%
Upside
Reiterated
06/24/26
Verastem (VSTM) Gets a Buy from Alliance Global Partners
Jefferies Analyst forecast on DE:2VSA
Faisal Khurshid
Jefferies
Jefferies
€12.96→€6.91
Buy
31.12%
Upside
Reiterated
06/23/26
Verastem price target lowered to $8 from $15 at JefferiesVerastem price target lowered to $8 from $15 at Jefferies
B. Riley Securities Analyst forecast on DE:2VSA
Unknown Analyst
B. Riley Securities
Not Ranked
B. Riley Securities
€13.82
Buy
162.25%
Upside
Initiated
05/22/26
Verastem (VSTM) Receives a Buy from B. Riley Securities
Cantor Fitzgerald Analyst forecast on DE:2VSA
Eric Schmidt FCA
Cantor Fitzgerald
Cantor Fitzgerald
―
Buy
―
Initiated
10/16/25
Verastem assumed with an Overweight at Cantor FitzgeraldVerastem assumed with an Overweight at Cantor Fitzgerald
Wolfe Research Analyst forecast on DE:2VSA
Kalpit Patel
Wolfe Research
Wolfe Research
€13.82
Buy
162.25%
Upside
Reiterated
10/10/25
B. Riley Securities Reaffirms Their Buy Rating on Verastem (VSTM)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Verastem

3 Months
Leonid TimashevRBC Capital
Success Rate
7/13 ratings generated profit
54%
Average Return
+22.82%
Copying Leonid Timashev's trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +22.82% per trade.
1 Year
Leonid TimashevRBC Capital
Success Rate
9/13 ratings generated profit
69%
Average Return
+18.58%
Copying Leonid Timashev's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +18.58% per trade.
2 Years
Leonid TimashevRBC Capital
Success Rate
10/13 ratings generated profit
77%
Average Return
+30.47%
Copying Leonid Timashev's trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +30.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2VSA Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
19
23
22
19
15
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
23
22
19
15
In the current month, 2VSA has received 15 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2VSA average Analyst price target in the past 3 months is 12.46.
Each month's total comprises the sum of three months' worth of ratings.

2VSA Financial Forecast

2VSA Earnings Forecast

Next quarter’s earnings estimate for 2VSA is -€0.38 with a range of -€0.43 to -€0.36. The previous quarter’s EPS was -€0.30. 2VSA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2VSA has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2VSA is -€0.38 with a range of -€0.43 to -€0.36. The previous quarter’s EPS was -€0.30. 2VSA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 2VSA has Performed in-line its overall industry.

2VSA Sales Forecast

Next quarter’s sales forecast for 2VSA is €25.25M with a range of €23.05M to €27.11M. The previous quarter’s sales results were €34.74M. 2VSA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2VSA has Performed in-line its overall industry.
Next quarter’s sales forecast for 2VSA is €25.25M with a range of €23.05M to €27.11M. The previous quarter’s sales results were €34.74M. 2VSA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 2VSA has Performed in-line its overall industry.

2VSA Stock Forecast FAQ

What is DE:2VSA’s average 12-month price target, according to analysts?
Based on analyst ratings, Verastem’s 12-month average price target is 12.46.
    What is DE:2VSA’s upside potential, based on the analysts’ average price target?
    Verastem has 136.49% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Verastem a Buy, Sell or Hold?
          Verastem has a consensus rating of Strong Buy, which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Verastem’s share price target?
            The average share price target for Verastem is 12.46. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €15.55 ,and the lowest forecast is €6.91. The average share price target represents 136.49% Increase from the current price of €5.27.
              What do analysts say about Verastem?
              Verastem’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of Verastem?
                To buy shares of DE:2VSA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.